These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9416643)

  • 1. Functional brain imaging and aging in schizophrenia.
    Buchsbaum MS; Hazlett EA
    Schizophr Res; 1997 Oct; 27(2-3):129-41. PubMed ID: 9416643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.
    Buchsbaum MS; Buchsbaum BR; Hazlett EA; Haznedar MM; Newmark R; Tang CY; Hof PR
    Am J Psychiatry; 2007 Jul; 164(7):1072-81. PubMed ID: 17606659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.
    Wolkin A; Jaeger J; Brodie JD; Wolf AP; Fowler J; Rotrosen J; Gomez-Mont F; Cancro R
    Am J Psychiatry; 1985 May; 142(5):564-71. PubMed ID: 3872603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
    Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA
    Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study.
    Farkas T; Wolf AP; Jaeger J; Brodie JD; Christman DR; Fowler JS
    Arch Gen Psychiatry; 1984 Mar; 41(3):293-300. PubMed ID: 6608333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.
    Ho BC; Andreasen NC; Nopoulos P; Arndt S; Magnotta V; Flaum M
    Arch Gen Psychiatry; 2003 Jun; 60(6):585-94. PubMed ID: 12796222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression.
    Kling AS; Metter EJ; Riege WH; Kuhl DE
    Am J Psychiatry; 1986 Feb; 143(2):175-80. PubMed ID: 3946650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography.
    Cohen RM; Semple WE; Gross M
    Psychiatr Clin North Am; 1986 Mar; 9(1):63-79. PubMed ID: 3515332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward a brain map of auditory hallucinations.
    Cleghorn JM; Franco S; Szechtman B; Kaplan RD; Szechtman H; Brown GM; Nahmias C; Garnett ES
    Am J Psychiatry; 1992 Aug; 149(8):1062-9. PubMed ID: 1353314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic subtypes in patients with schizophrenia.
    Clark CM; Kopala L; James G; Hurwitz T; Li D
    Biol Psychiatry; 1993 Jan; 33(2):86-92. PubMed ID: 8439608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients.
    Vita A; Bressi S; Perani D; Invernizzi G; Giobbio GM; Dieci M; Garbarini M; Del Sole A; Fazio F
    Am J Psychiatry; 1995 Jun; 152(6):876-82. PubMed ID: 7755117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.
    Soyka M; Koch W; Möller HJ; Rüther T; Tatsch K
    Eur Arch Psychiatry Clin Neurosci; 2005 Oct; 255(5):308-12. PubMed ID: 15834758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebral glucose metabolism in schizophrenia. Studies using positron-emission tomography].
    M'Rabet N; Lotstra F; Goldman S; Delvenne V; Mendlewicz J
    Acta Psychiatr Belg; 1991; 91(6):311-26. PubMed ID: 1670424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics.
    Buchsbaum MS; Haier RJ; Potkin SG; Nuechterlein K; Bracha HS; Katz M; Lohr J; Wu J; Lottenberg S; Jerabek PA
    Arch Gen Psychiatry; 1992 Dec; 49(12):935-42. PubMed ID: 1360198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frontal glucose utilization in chronic schizophrenia: a replication study.
    Wolkin A; Angrist B; Wolf A; Brodie JD; Wolkin B; Jaeger J; Cancro R; Rotrosen J
    Am J Psychiatry; 1988 Feb; 145(2):251-3. PubMed ID: 3257653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine effects on glucose metabolic rate in striatum and frontal cortex.
    Potkin SG; Buchsbaum MS; Jin Y; Tang C; Telford J; Friedman G; Lottenberg S; Najafi A; Gulasekaram B; Costa J
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():63-6. PubMed ID: 7961576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current status of PET scanning with respect to schizophrenia.
    Sedvall G
    Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography studies of abnormal glucose metabolism in schizophrenic illness.
    Buchsbaum MS
    Clin Neurosci; 1995; 3(2):122-30. PubMed ID: 7583618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task.
    Holcomb HH; Lahti AC; Medoff DR; Weiler M; Dannals RF; Tamminga CA
    Am J Psychiatry; 2000 Oct; 157(10):1634-45. PubMed ID: 11007718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.